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INTRODUCTION 
Interest in enzymes catalyzing glucose phosphorylation 
has been considerable ever since 1927 when Meyerhof obtained 
an enzyme from yeast extracts that enabled old muscle juice 
to regain its ability to ferment sugars. The Meyerhof 
enzyme, termed hexokinase (ATP;D-hexose-6 phosphotransferase, 
EC 2.7.1.1), was found to be identical to the yeast enzyme, 
heterophosphatese, which von Euler and Adler (1935) and 
Lutwak-Mann and Mann (1935) also found to be capable of 
catalyzing the transfer of the terminal phosphoryl group of 
ATP to a number of hexoses according to the following 
reaction; 
D-Hexose + MgATP^\ 1 D-Hexose-G-P'" + MyADP^" + h"^ 
Although the enzyme is apparently ubiquitous in nature, the 
yeast and mammalian enzymes are probably the best character­
ized. The yeast enzyme has been studied extenso with 
regard to its kinetic and physical properties. In fact, a 
number of new kinetic techniques for evaluating multisubstrate 
kinetic mechanisms with regard to the order of substrate 
addition and product removal were used during their develop­
ment to study the yeast enzyme. These include the use of 
product inhibitors (Fromm and Zewe, 1962b; Zewe, Fromm, and 
Fabiann. 1964: Fromm. 1968), substrate analogs as competitive 
inhibitors (Fromm and Zewe, 1962b; Zewe^ Fromm, and Fabiano, 
1964) , isotope exchange at equilibrium (Fromm, Silverstein, 
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and Boyer, 1964), and alternative substrates and products 
(Fromm and Zewe, 1962b; Froinin, 1964) . In addition, there 
has been a lasting interest in the ATP-phosphohydrolase 
activity of the yeast enzyme (Kaji and Colowick, 1965; 
Trayser and Colowick, 1961; Rudolph and Fromm, 1971). On the 
other hand, the mammalian hexokinases have been examined 
largely with interest in their regulatory properties. As 
early as 1945, Utter, Wood, and Reiner reported that cen-
trifugation of rat brain homogenates resulted in substantial 
loss of hexokinase activity, and this finding may have been 
the basis for the suggestion of Meyerhof and Geliazkowa 
C1947) that the enzyme exists primarily in a bound form in 
marked contrast with the other soluble glycolytic enzymes. 
In addition, there has been great interest in the manner in 
which mammalian hexokinase activity is coordinated with 
phosphofructokinase to provide for effective control of 
glycolysis. 
Over the years since Meyerhofs discovery of the hexo­
kinase reaction, there have been numerous studies that have 
contributed to our present understanding of the mode of 
action and regulation of the hexokinases. A complete discus­
sion of these investigations of yeast and mammalian hexo­
kinases is clearly beyond the scope of this introduction 
which will be restricted to the mammalian brain enzyme. For 
a more extensive treatment of this topic, the reader is 
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referred to a forthcoming review by Rudolph, Purich, and 
Froitun (1973). 
Early investigations of glucose-6-P inhibition of brain 
hexokinase suggested that this sugar-P acted as a specific 
potent noncompetitive product inhibitor relative to the sugar 
substrate. This conclusion was alluded to when it was 
observed that high concentrations of glucose did not reverse 
the inhibition of glucose-6-P. Weil-Malherbe and Bone (1951) 
concluded from such studies that glucose and glucose-6-P 
occupy separate sites on the brain enzyme, and Crane and Sols 
(1953) came to a similar conclusion. Later studies by Crane 
and Sols (1954) showed that low levels (^<100 yM) brought 
about potent inhibition of brain hexokinase whereas other 
possible reaction products such as 2-deoxyglucose-6-P, 
mannose-6-P, and fTUctose-6-P were considerably less effec­
tive. They also found that sorbose-1-P and 1,5-anhydro-
glucitol-6-P were also excellent inhibitors. It was this 
specificity of product inhibition and their observation of 
noncompetitive inhibition relative to glucose that led Crane 
and Sols (1954) to conclude that brain hexokinase possesses 
a glucose-6-P specific allosteric site. 
In 1954, Racker proposed that the potent glucose-6-P 
inhibition of mammalian hexokinases might play an important 
role in the Pasteur effect which refers to the acceleration 
of the glycolytic rate when respiration is prevented by 
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anaerobiosis. Subsequent studies by the Backer group estab­
lished that the maximal in vivo hexokinase activity was con­
sistently lower than the optimal activity of any other 
glycolytic enzyme in ascites tumor cells, HeLa cells, chicken 
leukocytes, and mouse brain, and that only with hexokinase 
was a considerable portion of any glycolytic eraymatic 
activity associated with particulate fractions' (Wu and 
Backer, 1959a,b; Backer, 1965). Lowry and Passonneau (1964) 
concluded on the basis of a similar analysis and additional 
experiments on the effects of anoxia on the intracellular 
content of key glycolytic intermediates that the hexokinase 
and phosphofructokinase reactions were the important regu­
latory steps in brain glycolysis. 
Backer has also provided several studies that illustrate 
the functional significance of differences between the 
mammalian and yeast enzyme which is only weakly inhibited by 
glucose-6-P (Fromm and Zewe, 1962b). The early experiments 
of Gatt and Backer (1959) with reconstructed glycolytic 
systems were performed using highly purified enzymes in pro­
portion to their measured optimal enzymic activities. All of 
these enzymes were purified from rabbit muscle with the 
exception of yeast hexokinase which was the only highly 
purified and soluble hexokinase available. In the presence 
of mitochondria and the reconstructed glycolytic system, 
competition for common cofactors such as and ADP was 
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observed. In the presence of limiting concentrations of 
and ADP, respiration was inhibited whenever the glycolytic 
enzymes predominated, and the rate of lactate production was 
inhibited whenever the mitochondria were present. Although 
these phenomena resembled the well-known Pasteur effect 
(1876) and Crabtree effect (1929) observed in intact cells, 
the inhibition of lactate production in the reconstructed 
systems was accompanied by an accumulation of a rather large 
amount of fructose-l,6-diP which is not characteristic of 
these effects as observed ^  vivo. A re-examination of 
similar reconstructed systems by Uyeda and Backer (1965a,b) 
in the presence of ascites tumor hexokinase demonstrated 
that the source of hexokinase activity greatly affected the 
behavior of the entire reconstructed pathway. The Pasteur 
and Crabtree effects could again be demonstrated, but, more 
significantly, there was no fructose-l,6-diP accumulation or 
change in the glucose-6-P level even at greatly different 
rates of the overall reaction sequence. Thus, use of mamma­
lian hexokinase in place of the yeast enzyme brought the 
properties of the reconstructed pathway into qualitative 
agreement with events occurring ^  vivo. Moreover, the obser­
vation that the glucose-6-P level did not change appreciably 
suggested that the rates of the hexokinase and phosphofructo-
kinase reactions are rigorously coordinated. Uyeda and Backer 
(1965a,b) suggested that P^ played a major role by countering 
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the glucose-6-P inhibition of tumor hexokinase. Such an 
observation would be in agreement with the observation of 
Rose and O'Connell (1964) that glucose-6-P inhibition of red 
cell hexokinase is diminished in the presence of ortho-
phosphate . 
In 1962, initial rate studies of the particulate calf 
brain enzyme were carried out in order to define the kinetic 
reaction mechanism (Fromm and Zewe, 1962b). These investi­
gators found that Lineweaver-Burk type plots of the initial 
reaction velocity dependence on one substrate at several 
constant levels of the other substrate were parallel, sug­
gesting that a covalent enzyme-substrate intermediary was 
formed in the course of the reaction. In addition, their 
studies of the glucose-6-P inhibition indicated that the 
sugar-P product was a linear competitive inhibitor relative 
to ATP and a noncompetitive inhibitor with respect to glucose. 
That glucose-6-P and ATP compete for the same locus on the 
enzyme was clear evidence against an allosteric role for 
glucose-6-P as proposed earlier by Weil-Malherbe and Bone 
(1951) and Crane and Sols (1954). The competitive nature of 
the glucose-6-P with respect to ATP was rationalized in terms 
of a common binding site on the enzyme for the 6-phospho and 
K-phosphoryl groups on glucose-6-P and ATP, respectively. 
Fromm and Zewe (1962b) also found that ADP inhibition relative 
to either substrate was noncompetitive, and suggested that 
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this type of inhibition could result from ADP binding at the 
ADP site on the phosphoryl-enzyme and the ATP site on the 
free uncomplexed enzyme. Similar results were observed by 
Hanson and Fromm (1965) for the soluble brain isozyme iso­
lated from rat skeletal muscle and by Copley and Fromm (1967) 
for the Triton X-100 solubilized bovine brain enzyme. In 
contrast, Hanson and Fromm (1967) found that the rat skeletal 
muscle isozyme had kinetic properties similar to the yeast 
enzyme, for which a rapid equilibrium random mechanism appar­
ently pertains on the basis of numerous kinetic experiments 
(Fromm and Zewe, 1962b; Fromm, Silverstein, and Boyer, 1964; 
Rudolph and Fromm, 1971). More recent studies of the kinetic 
mechanism of the bovine brain enzyme have shown that (a) the 
kinetic properties of the bovine brain enzyme are most 
reasonably rationalized in terms of a rapid equilibrium 
random mechanism, (b) the enzyme catalyzes the reverse reac-
2+ 
tion at elevated levels of Mg at pH 6.5 where the apparent 
equilibrium constant for the hexokinase reaction is only 490, 
(c) pyrimidine nucleotides can only bind at the ATP site, and 
(d) ADP inhibition arises from binding at an inhibitory 
nucleotide site that is distinct from the active site on the 
basis of kinetic criteria (Ning, Purich, and Fromm, 1969). 
It appeared advantageous to reinvestigate the properties 
of rat brain hexokinase to determine whether the kinetic 
observations with the bovine enzyme represent general features 
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of mammalian brain hexokinases. Furthermore, since the 
analytical concentrations of the various hexokinase effectors 
in rat brain are available in the literature, it was felt 
that the direct effects of these compounds on soluble and 
particulate brain hexokinase could be evaluated. Moreover, 
the effects of these metabolites on the dm vitro soluble-
particulate distribution of hexokinase activity could be 
measured. The role of and MgATP^ in the hexokinase 
reaction was also studied. Finally, the response of brain 
hexokinase to the adenylate energy charge was evaluated under 
simulated intracellular conditions. 
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EXPERIMENTAL PROCEDURE 
Mannitol, D-glucose, and D-fructose were obtained from 
Pfanstiehl Laboratories, Waukegan, Illinois. D-Glucose^6-P 
dehydrogenase, DPNH, glucose-6-P, PEP, rabbit skeletal muscle 
lactate dehydrogenase (specific activity, 750^1500 units/mg), 
rabbit skeletal muscle pyruvate kinase (specific activity, 
178 units/mg), and yeast hexokinase (200 units/mg) were 
products of Calbiochem. ATP, GTP, UTP, ADP, GDP, UDP, AMP, 
GMP, UMP, TPN* and phosphoglucoisomerase were purchased from 
Sigma Chemical Company. Analytical grade Dowex 1-X2 (200-400 
mesh) was obtained from Bio-Rad Laboratories, Richmond, 
California. Uniformly labeled D-glucose-^*C (specific 
radioactivity, 240 mCi/mmole) was the product of Schwartz 
Bio-Research. Ion-low water, obtained from passage of 
distilled water through a Rohm and Haas MB-3 resin bed, was 
used to prepare all reagents. 
Male Wistar strain rats (200-250 g), obtained from 
Schettle Biologicals, St. Paul, Minnesota, were allowed free 
access to Kent animal feed pellets and water. The animals 
were maintained on this diet for no more than 2 weeks before 
they were sacrificed. On occasion, male rats were also 
obtained from the rat colony maintained at the Department of 
Food and Nutrition, Iowa State University. 
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standard Hexokinase Assay Determination of hexo-
kinase activity during the purification was made by observing 
the absorbancy increase at 340 nm accompanying conversion of 
TPN* to TPNH. The routine assay mixture contained in a total 
volume of 2.0 ml, 50 mM Tris-HCl (pH 7.4), 25 mM D-glucose, 
0.5 mM TPN*, 3.7 mM ATP, 7.4 mM MgCl^, 5 mM 2-mercaptoethanol, 
and approximately 1 international unit of glucose-6-P dehydro­
genase. The reactions were followed at 28°C in a Gary model 
15 recording spectrophotometer with a thermostatted cell 
housing. One unit of activity is defined as the amount of 
enzyme required to catalyze the reduction of ly mole of TPN* 
per min. 
Protein Determination The protein concentration was 
determined by use of the Biuret method (Gornall et al., 1949) 
with bovine serum albumin as a standard. Specific activity 
is expressed as units of enzyme activity per mg of protein. 
TPN"*" Assay TPN* concentration was assayed spectro-
photometrically on the basis of its molar extinction coeffi­
cient, 18.0 X 10^ M~^cm~^, at pH 7.0 and 260 nm. Stock 
solutions were stored at -15° when not in use. 
DPNH Assay DPNH concentration was assayed spectro-
photometrically on the basis of its molar extinction coeffi-
3 -1 -1 
cient, 6.2 X 10 M cm , at pH 8 and 340 nm. Stock 
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solutions were prepared immediately prior to use by dissolving 
the sodium salt of this nucleotide directly into buffer. 
Nucleotide Concentration and Purity Concentrations 
used in this study were determined from their characteristic 
ultraviolet absorption (P-L Laboratories Circular OR-24). 
The purity of the nucleotides was determined by chromatog­
raphy on DEAE-cellulose ion-exchange paper essentially as 
described by Morrison (1968). The developing solvent was 
prepared by a 1:5 dilution (v/v) of a 0.6 M ammonium formate-
0.005 M EDTA solution which was adjusted to pH 3.1 by the 
addition of concentrated formic acid. Only those nucleotides 
that appeared homogeneous under ultraviolet illumination 
were used. 
Glucose Assay Glucose concentration was enzymatically 
determined using commercial yeast hexokinase and glucose-6-P 
dehydrogenase. Reaction mixtures (3.0 ml final volume) 
contained 0.5 mM ATP, 1.5 mM MgSO^, 0.05 M Tris-HCl buffer 
tpH 7.6), 0.3 mM TPN^f and a substantial excess of yeast 
hexokinase and glucose-6-P dehydrogenase. The assay also 
contained from 0.1 to 0.2 mM D-glucose or water which served 
as the absorbance blank. Optical density measurements were 
made at 340 nm in a Beckman DU spectrophotometer fitted with 
a Gilford model 220 optical density converter. 
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The purity of C-D-glucose was confirmed by ascending 
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paper chromatograph on Whatman 3M paper using 70% n-propanol. 
Dried chromatograms were subjected to radioautography, and 
it was found that more than 98% of the radioactivity was 
concentrated in a single spot. The location corresponded 
to an approximate of 0.5. 
Fructose Assay The concentration of stock fructose 
solutions was estimated as with glucose but in the presence 
of rabbit phosphoglucoisomerase. Stock solutions were stored 
at -15* when not in use. 
Preparation of Brain Hexokinase A modification of 
the procedure of Grossbard and Schimke (1966) was utilized. 
Rats were killed by a blow to the head, decapitated, and the 
entire brain was removed and placed on ice. Brain (27 g) was 
homogenized in a hand operated Potter-Elvehjem homogenizer 
fitted with a teflon pestle in an equal volume of ice-cold 
0.01 M potassium phosphate buffer, pH 7.0, containing 5 mM 
2-mercaptoethanol, 5 mM disodium EDTA, and 10 mM glucose. 
(This buffer is hereafter referred to as Standard Buffer). 
The homogenate was centrifuged at 30,000 x g for 30 min in a 
Sorvall refrigerated centrifuge, and the supernatant extract 
('^25 ml) was decanted and retained. The tissue was then 
extracted with 15 ml Standard Buffer, re-centrifuged as 
above, the supernatant fluids were combined, and dialyzed 
against 2000 ml of Standard Buffer in a continuous flow 
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rocking dialyzer. 
The dialysate (45 ml) was then applied to a Whatman 
DE-52 DEAE-cellulose anion-exchange column, 1.0 x 13.0 cm, 
that was packed under approximately 1 pound pressure of 
nitrogen. The column was washed with Standard Buffer (150 ml), 
and then developed with a 250 ml linear gradient from 0 to 
0.6 M KCl in Standard Buffer. Type I hexokinase, the first 
hexokinase activity to issue from the column, was collected 
and dialyzed for approximately 4 hours against 2000 ml 
Standard Buffer. It was reapplied to a 1 x 4 cm DEAE-
cellulose column which had been equilibrated with Standard 
Buffer. The enzyme was eluted with the same buffer containing 
0.15 M KCl, and solid glucose was added to a concentration of 
0.1 M. The eluate was concentrated by dialysis against dry 
Sephadex G-25 (coarse) and purified through the first ammonium 
sulfate fractionation as described by Grossbard and Schimke 
(1966). 
The enzyme (specific activity, 0.5 units/mg) , which was 
stable for months in neutral 3.0 M ammonium suifate-0.01 M 
glucose, was exhaustively dialyzed against 0.05 M Tris-HCl 
(pH 7.6) immediately prior to use. It was also shown to be 
free of glucose-6-phosphatase, ATPase, and myokinase. 
Magnesium Ion Levels The concentration of free 
uncomplexed magnesium ion (as MgSO^) was rigorously controlled 
in all experiments. Calculation of the proper Mg^*:ATP*" 
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ratio in Tris-HCl (pH 7.6) was based upon a value of 20,000 
m"^ for the MgATP^" complex (0'Sullivan and Perrin, 1964). 
Similar calculations were made for MgADP^ and MgAMP assuming 
stability constants of 2,000 and 100 M respectively (Bock, 
1960). When HEPES buffer was utilized, adjustments were made 
assuming a value of 100,000 M ^ for the MgATP^ complex 
(Rudolph and Fromm, 1969). 
Kinetic Measurements Initial velocity measurements 
were made in a Gary model 15 spectrophotometer maintained at 
28°. All reactions were initiated by the addition of the 
brain enzyme. Initial rates of glucose-6-P production were 
assayed with a coupled enzyme system containing, in addition 
to the other components, 60 yM TPN^, Tris-HCl (pH 7.6), and 
a substantial excess of glucose-6-P dehydrogenase. When 
fructose was employed as the sugar substrate, excess phospho-
glucoisomerase was added to the above solution. Initial rates 
of ADP production were evaluated by use of a coupled enzyme 
system containing, in addition to other components, 10 mM 
potassium chloride, 0.5 mM P-enolpyruvate, 50 yM DPNH, and an 
excess of lactate dehydrogenase and pyruvate kinase (Copley 
and Fromm, 1967). In those experiments where both glucose-6-P 
and the nucleoside 5'-diphosphates were present as inhibitors, 
the initial rate of conversion of radioactive glucose to 
radioactive glucose-6-P was measured. The reactions were 
stopped by boiling for 1 min. Samples were assayed at various 
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time intervals to ensure linearity with time, and blanks were 
analyzed at each time and each glucose concentration. Ten 
milliliters of 40 mM glucose were added to the boiled reaction 
mixture, and 10 ml of the sample were washed onto an AG1-X2-C1 
column (2x4 cm) which had been exhaustively washed with 
water and then equilibrated with 40 mM glucose. The column 
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was then washed with 50 ml of 40 mM glucose to remove the C-
glucose present. Finally, 50 ml of HgO were passed through 
the column, and the glucose 6-phosphate was removed with 0.1 N 
HCl. Ten milliliters of the acid effluent were collected in a 
volumetric flask, and 2 ml of this solution were placed in 15 
ml of the naphthalene-dioxane fluid and counted. A Packard 
Tri-Carb liquid scintillation spectrometer was used for all 
counting. Unless otherwise stated, velocities in all experi­
ments are expressed as molarity of product formed per min. 
Estimated Intracellular Metabolite Levels Estimation 
of the intracellular metabolite concentrations requires con­
version of analytical data (usually expressed in terms of 
micromoles per g of fresh tissue) into units of molarity. 
Corrections were made for the volumes of blood, cerebrospinal 
fluid, and extracellular space. These values were taken to be 
3, 9, and 20%, by volume, respectively (Bachelard and Mcllwain, 
IQ^Q* 1 O 7 A \ TATa f a o cm m A 
that the tissue is 80% water and that the metabolites are 
uniformly distributed throughout the cell. This latter 
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assumption requires that metabolite concentration gradients 
are reasonably small, if present, and that the mitochondrial 
adenylate pool does not constitute a large fraction of the 
total adenylate pool. This is justified in part by the obser­
vation that rat brain mitochondria have lower concentrations 
of adenylates than other mitochondria (Clark and Nicklas, 
1970). Analytical values for ATP, AMP, and glucose-6-P (Lowry 
et ^ ., 1964) were corrected to 4.4, 0.4, and 0.15 mM, respec­
tively, The ADP level was calculated to be 0.75 mM based upon 
an analytical concentration of 0.5 ymole per g of tissue 
(Lowry, 1969). Values for GTP (Tarr et ^., 1962) and UTP 
(Tarr et al., 1962; Schmitz et al., 1954) were corrected to 
1.5 and 1.3 mM, respectively. Similarly, the analytical level 
of Pj^  was corrected to 9.2 mM (Mcllwain, 1966). Finally, the 
2+ intracellular concentration of "free" nonparticulate Mg was 
taken to be 1.5 mM (Bachelard and Goldfarb, 1969). 
Determination of Soluble-Particulate Distribution of 
Hexokinase Activity Each study on the soluble-particulate 
distribution of hexokinase used freshly prepared mitochondria 
from a single rat brain (1.9 to 2.0 g). The procedures out­
lined here are similar to those used to study the distribution 
of hexokinase activity in ascites tumor cells and bovine 
cerebral cortical tissue (Rose and Warms, 1967). The animal 
was killed by suffocation in a nitrogen atmosphere and its 
brain immediately removed intact. The whole rat brain was 
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homogenized in 10 ml of 0.25 M mannitol in a hand-operated 
Potter-Elvehjem homogenizer. The homogenate was freed of 
cellular debris by centrifugation at 800 x g for 25 min, and 
the supernatant solution was collected and centrifuged at 
15,000 X g for 1 hour. The mitochondrial pellet was washed 
three times by suspension in mannitol solution with the homoge­
nizer and centrifugation as above. Finally, the mitochondria 
were evenly suspended in 10 ml of mannitol solution in a 
similar manner. This material, when incubated at 36° for 30 
min in the presence of 25 mM Tris-HCl (pH 7.6), had no detect­
able hexokinase activity in the supernatant fluid obtained 
after centrifugation at 15,000 x g for 1 hour. 
Aliquots of the mitochondrial suspension were incubated 
at 36° for 30 min in the presence of the various compounds 
listed in the text. Next, the 3.0-ml samples were cooled in 
an ice bath and centrifuged at 15,000 x g for 1 hour. The 
supernatant solution was carefully decanted and then the walls 
and pellet were gently washed with 7.0 ml of mannitol solution 
which was removed and combined with the previous décantant. 
The pellet was transferred to a homogenizer with 10 ml of 
mannitol solution and evenly suspended. A 0.025-ml aliquot 
was assayed for hexokinase activity, and the activity is 
reported as the percentage of hexokinase remaining associated 
with the mitochondrial pellet after treatment. No correction 
was necessary for time-dependent changes in turbidity. 
18 
Correction of Rate Data to Account for the Cone entrât ion 
Dependent Stability of MgATP^ To estimate the true 
2-  4-
MgATP complex concentration over a range of and 
2+ 
concentrations, the following quadratic equation was 
solved for the real root; 
(1 + KMq + KAQ) ± y(1 + KMQ + KAQ)^ - 4K^MQAQ 
(MA) = ; 
2K 
MA/ K, Mçj/ and A^ represent the MgATP^" concentration, the 
stability constant for the MgATP^ complex, total magnesium 
AM 
ion concentration, and total ATP concentration. K was 
taken to be 73,000 M ^ for MgATP^ in 0.15 M triethanolamine-
HCl, pH 7.6 (O'Sullivan and Perrin, 1964; Bachelard, 1971b). 
2"" Corrections of the MgATP ~ concentration in the initial rate 
experiments of Bachelard (1971b) to account for the MgATP^~ 
stability were made on photographic enlargements of published 
figures. 
19 
RESULTS AND DISCUSSION 
Initial Velocity Measurements and Kinetic Reaction 
Mechanism In earlier studies of rat brain hexokinase, 
glucose was utilized as the sugar substrate (Hanson and Fromm, 
1965). Lineweaver-Burk type plots of their initial rate data 
yielded parallel lines when either substrate was varied at 
different constant levels of the second substrate. These 
results were taken as evidence for the participation of an 
enzyme-glucosyl or enzyme-phosphoryl intermediary [i.e. the 
kinetic mechanism was Ping-Pong]. Scheme I depicts the model 
that appeared to be most reasonable in view of the above 
initial rate data. In this model, E, A, EA, E', P, B, E'B, 
ki kg 
E + A \ ^ EA^ > E' + P 
^2 ^4 
kg k^ 
E' + B ^ ^E'B ^  AE + Q 
6^ 8^ 
Scheme I 
and Q are taken to represent free enzyme, substrate A, enzyme 
substrate A Michaelis complex, the covalent enzyme-substrate 
intermediary, product P, substrate B, covalent enzyme-substrate 
substrate B Michaelis complex, and product Q. The rate 
1.UI. uiixa uieuxiaiixaiu a.ii j.ai 
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where the jS values are collections of rate constants as first 
defined by Dalziel (1957), and and v are total enzyme 
concentration and initial reaction velocity, respectively. 
Similar parallel-line reciprocal plots have been observed with 
particulate and solubilized calf brain hexokinase (Fromm and 
Zewe, 1962a; Copley and Fromm, 1967). Recently, studies of 
bovine brain hexokinase, however, indicated that the mechanism 
appeared sequential when fructose was utilized as the sugar 
substrate (Fromm and Ning, 1968). Their findings were consis­
tent with either of the general two substrate mechanisms shown 
in Scheme 2. 
E + A ^  ^ EA 
^2 
^3 ^5 
EA + B ^ ^ EXY-^ ^EQ + P 
^4 ^6 
^7 
EQ \ ^ E + Q 
^8 
A. Ordered Ternary Complex Mechanism 
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Figure 1. Plot of the reciprocal of the initial reaction 
velocity (v) versus the reciprocal of the molar 
concentration of ATP 
Fructose concentrations were held constant at 
1.11 mM CP), 1.43 mM (0), 2.00 mM (O) , 3.33 mM (e) , 
and 10.0 mM (A) ; v was determined as a function of 
ATP concentration in the range from 0.28 to 2.5 mM. 
Other experimental details are described under 
"Experimental Procedure." 
22 
(l/Fruc10M)*IO'^M 
Figure 2. Plot of the reciprocal of the initial reaction 
velocity (v) versus the reciprocal of the molar 
concentration of fructose 
ATP concentrations were held constant at 0.28 mM 
(A), 0.36 mM (*), 0.50 mM (O), 0.83 mM (A), and 
2.5 mM (•) ; v was determined as a function of 
fructose concentration in the range frœi 1.11 to 
10.0 mM. Other experimental details are described 
under "Experimental Procedure." 
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B. Rapid Equilibrium Random Mechanism 
Scheme II 
It was originally shown by Alberty (1953) that the rate 
expression for a sequential mechanism will contain an (A)(B) 
term. When expressed in Dalziel form, the general rate 
equation for sequential kinetic mechanisms is: 
^o , . *1 ^2 . %2 
= 1 + + —S— + (2) 
V (A) (B) (A) (B) 
It is clear that plots of 1/v versus 1/A or 1/B at several 
constant levels of B or A, respectively, will result in both 
slope and intercept changes (i.e., the lines converge). When 
similar studies were carried out with rat brain hexokinase, 
the data presented in Figs. 1 and 2 were obtained. The data 
suggest that the kinetic mechanism with fructose as the sugar 
substrate is sequential, and that the (B) apparently 
is not appreciable with glucose as the sugar substrate. 
To discount the unlikely possibility that rat brain 
hexokinase possessed separate sugar binding sites and catalyzed 
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two independent phosphorylation reactions, one sequential 
(with fructose) and the other Ping-Pong (with glucose), 
further studies were carried out. It was found that the 
alternative substrate, D-fructose, competed with D-glucose 
for the same site on the brain enzyme. This was established 
by the results of the experiment presented in Fig. 3. The 
initial rate of glucose-6-P production was measured by using 
glucose-6-P dehydrogenase which is specific for D-glucose-6-P 
and will not utilize fructose-6-P. 
Studies of AMP inhibition of rat (Hanson and Fromm, 
1965) and bovine brain hexokinase (Fromm and Zewe, 1962a; 
Copley and Fromm, 1967) indicated that AMP was a noncompeti­
tive inhibitor relative to either substrate. These data were 
compatible with the Ping-Pong mechanism if it was assumed 
that AMP could bind to the two enzyme forms, E and E' (i.e., 
AMP binds at the ATP and ADP sites on the enzyme. Such 
behavior is, for example, observed with the Escherichia coli 
acetate kinase for which there is both chemical (Anthony and 
Spector, 1970) and kinetic (Purich and Fromm, 1972a) evidence 
for the participation of a phosphoryl-enzyme intermediary. 
On the other hand, the behavior of AMP in the brain hexokinase 
reaction is not consistent with sequential pathways of enzyme 
and substrate interactions. Ning, Purich, and Fromm (1969), 
however, demonstrated that one could reconcile the AMP data 
with a rapid equilibrium random mechanism if one postulates 
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Figure 3. Plot of the reciprocal of initial reaction 
velocity (v) versus the reciprocal of the molar 
concentration of glucose in the absence and 
presence of fructose 
ATP concentration was maintained at 0.5 mM, and 
fructose concentrations were held constant at none 
07), 1.0 mM (O), and 3.0 mM (•); v was determined 
as a function of glucose concentration which was 
varied in the range from 0.11 mM to 1.0 mM. Other 
experimental details are described under "Experi­
mental Procedure." 
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the existence of an additional nucleotide site topologically 
distinct from the ATP substrate site. The following experi­
ments were carried out to demonstrate that a similar mecha­
nism and nucleotide site pertains in thô rat brain hexokinase 
reaction. 
The use of competitive inhibitors of reaction substrates 
permits segregation of possible sequential mechanisms (Fromm, 
1964; Zewe, Fromm, and Fabiano, 1964; Zewe and Fromm, 1965). 
The idea involved when using competitive inhibitors is that 
one observes unique inhibition patterns for random and 
ordered mechanisms as is illustrated in Table 1. 
Table 1. Inhibition Patterns of Competitive Substrate 
Inhibitors for Several Bisubstrate Reactions 
Ordered Ternary 
Complex 
Theorell-Chance 
(Binary Complex) 
Rapid Equilibrium 
Random 
Competitive Inhib­
itor for substrate 
A 
B 
A 
B 
A 
B 
Inhibition relative 
to other substrate 
Mixed 
Uncompetitive 
Mixed 
Uncompetitive 
Noncompetitive 
Noncompetitive 
One may therefore use competitive inhibitor studies to "rule 
out" mechanisms whose theoretical inhibition patterns fail to 
conform to the experimentally observed mode of inhibition. 
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The findings presented in Figs. 4 and 5 indicate that 
N-acetyl glucosamine behaves as a linear competitive inhib­
itor relative to glucose and as a noncompetitive inhibitor 
with respect to .MgATP^~. ATP^~ behaves as a linear competi­
tive inhibitor relative to MgATP^ but ATP^ inhibition with 
respect to glucose is noncompetitive (See Figs. 6 and 7). 
Equation 2 for the random mechanism in the absence of inhib­
itors can be rewritten in the following form: 
° TTvfvTW 
^ * 1ÂT* TST* (A) (B) 
The K's are dissociation constants for substrates from the 
several enzyme forms for mechanism A shown in Scheme II. 
If A in Equation 3 is taken to represent ATP and B is the 
sugar substrate, then for a competitive inhibitor of A such 
as ATP^~, the inhibitor CD may react with the enzyme forms 
as follows. 
E + I = EI, 
EI + B = EIB, Kg 
EB + I = EIB, K3 
The following rate expression (Equation 4) indicates that 
competitive inhibitors of the nucleotide substrate, would be 
expected to act as mixed inhibitors of the sugar substrate as 
shown in Fig. 7. 
28 
> 
(l/GlueoM)xlO*^M 
Figure 4. Plot of reciprocal of initial velocity (v) against 
reciprocal of molar concentration of glucose in 
the absence and presence of N-acetylglucosamine 
ATP was held constant at 0.5 mM and glucose was 
varied in the concentration range from 0,11 to 1.0 
mM. N-Acetylglucosamine concentration was none 
(A), 0.4 mM (0), and 0.8 mM (V) • Other experi­
mental details are described under "Experimental 
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Figure 5. Plot of reciprocal of initial velocity (v) against 
reciprocal of molar concentration of ATP in the 
absence and presence of N-acetylglucosamine 
Glucose concentration was held at 0.2 mM and ATP 
varied in the concentration range of 0.228 to 2,50 
mM. N-Acetylglucosamine concentration was none (0), 
0.4 mM (A) / and 0.8 mM (0) . Other experimental 
details are described under "Experimental Procedure." 
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> 
(I/ATP) xlO'^M 
Figure 6. Plot of reciprocal of initial velocity Cv) against 
reciprocal of molar concentration of MgATP^" in 
the absence and presence of ATP*" 
Glucose was held constant at 0.2 mM and MgATP 
was varied in the concentration range from 0.22 to 
4-2.0 mM. ATP concentration was maintained at 0.5 
mM (0) and 1.5 mM (•). Other experimental details 
are given under "Experimental Procedure." 
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Figure 7. Plot of reciprocal of initial velocity (v) against 
reciprocal of molar concentration of glucose in 
the absence and presence of ATP*" 
MgATP ~ was held constant at 0.5 mM and glucose 
was varied in the concentration range 0.11 to 1.0 
rtiM. ATP*" concentrations were 0.5 mM (O) and 1.5 
mM CD). All reactions were carried out in 0.020 M 
HEPES CpH 7.6). Other experimental details are 
given under "Experimental Procedure." 
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V_ 
V = m 
1 + 
-h K-
Vd 
+ "B + (A) (B) 
(4) 
N-Acetylglucosamine is also expected to function as a mixed 
inhibitor of ATP in a pathway involving random interaction 
of enzyme and substrate. The reaction of N-acetylglucosamine 
(I) with the enzyme is: E + I = EI, K^; EI + A = EIA, Kg: 
EA + I = EIA, Kg. In the case of the random mechanism the 
following inhibited rate expression is obtained. 
V_ 
V = m 
, K& Kg I ' 
. % I ' 
1 + -5-+ -F 
r^J 
' (aKb) 
(5) 
It is clear that the results depicted in Figs. 4 to 7 are 
consistent with Equations 4 and 5, and it can be shown that 
these results are at variance with ordered sequential 
mechanisms (See Table 1). 
ADP Inhibition of Rat Brain Hexokinase Product 
inhibition studies are often a useful adjunct to initial 
velocity and competitive inhibition experiments. Although 
use of competitive inhibitors offers the most direct approach 
toward segregating two substrate sequential kinetic mecha-
nis"c, product inhibition studies can provide important 
supplemental information. Moreover, product inhibition 
represents one of the most fundamental and generally available 
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control phenomena known, and some possible roles for kinetic 
reaction mechanism-dependent product effects in cellular 
regulation have been recently discussed (Purich and Fromm, 
1972b). While a number of studies have focused on the 
potential regulatory role of glucose-6-P inhibition of 
mammalian hexokinases (Crane and Sols, 1954; Rose and 
O'Connell, 1964), surprisingly little attention has been 
given to the role of ADP inhibition. In 1969, Ning, Purich 
and Fromm presented evidence for an allosteric inhibition of 
solubilized bovine brain hexokinase. Unlike glucose-6-P, 
which is a linear competitive inhibitor with respect to 
MgATP (Fromm and Zewe, 1962a; Copley and Fromm, 1967) , these 
investigators observed that a plot of 1/v versus ADP was 
nonlinear. Moreover, they observed that the noncompetitive 
nature of the ADP inhibition with respect to either substrate 
could not be rationalized with simultaneous binding at both 
substrate sites. In the light of these observations, it was 
of interest to assess the effect of ADP on the soluble rat 
enzyme. Like the bovine brain enzyme, Hanson and Fromm 
(1965) found that ADP acted as a noncompetitive inhibitor 
relative to each substrate. 
The following experiments were carried out to exclude 
the possibility that the inhibitor bound simultaneously at 
the glucose and ATP loci on the enzyme resulting in an 
apparent noncompetitive inhibition relative to each substrate. 
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In Pig. 8 are presented the findings of an ADP inhibition 
experiment in which the glucose site was more than 98% 
saturated with glucose. The noncompetitive nature of the 
inhibition is quite apparent. It was reasoned that, had 
ADP bound to the glucose site in earlier experiments carried 
out in the neighborhood of the Michaelis Constant for 
glucose, 98% saturation of the site with glucose would have 
eliminated (if binding occurred exclusively at the sugar 
adsorption site) or the inhibition would have appeared com­
petitive with respect to ATP. A similar experiment, presented 
in Fig. 9, was undertaken in which the enzyme was 90% satu­
rated with ATP (i.e., ATP was maintained at a concentration 
ten-fold in excess of the Michaelis constant for ATP), and 
glucose was varied in the absence and presence of ADP. Again, 
inhibition relative to the sugar substrate was noncompetitive, 
suggesting that although ADP may bind at the ATP site, it 
also binds at a separate site topologically distinct from 
the binding sites for ATP and glucose. These results are 
essentially identical with corresponding studies of bovine 
brain hexokinase (Ning, Purich, and Fromm, 1969). No attempt 
was made, however, to demonstrate that two ADP molecules bind 
simultaneously. On the contrary, it appears that over the 
ADP concentration range indicated (0-9 mM) the ADP inhibi­
tion is linear noncompetitive. It is of interest to note 
that 1/v versus ADP plots of the ADP inhibition of the bovine 
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(I/ATP)X10-3M 
Figure 8. Plot of reciprocal of initial velocity (v) against 
reciprocal of molar concentration of ATP in the 
absence and presence of ADP 
Glucose concentration was held constant at 9.0 mM 
(approximately 50 x Kgiucose^ ATP was varied 
in the concentration range from 0.256 to 2.3 mM. 
ADP concentrations were none (0), 3.0 mM 07)* 6.0 
mM (•), and 9.0 mM (V) . Other experimental details 
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(I/Glucose) xlO'^M 
Figure 9. Plot of reciprocal of initial velocity (v) against 
reciprocal of molar concentration of glucose in the 
absence and presence of ADP 
ATP concentration was held constant at 5.0 mM 
(approximately 10 x K^^p) and glucose was varied 
in the concentration range from 0.1 to 0.9 mM. ADP 
concentrations were none C^), 2.5 mM CO), 5.0 mM 
CA) / and 7.5 mM (•)• Other experimental details 
are described under "Experimental Procedure." 
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brain enzyme are also linear in this range (Ning, Purich, 
and Promm, 1969). 
Pyrimidine Nucleotide Inhibition of Rat Brain Hexokinase 
Studies of bovine brain hexokinase indicated that purine 
nucleotides, except ATP, bound at the allosteric inhibitory 
nucleotide site and possibly at the ATP site as well (Ning, 
Purich, and Promm, 1969). On the other hand, pyrimidine 
nucleotides bound only at the ATP site as indicated by their 
action as linear competitive inhibitors relative to ATP. 
It was of interest to determine if this specificity was a 
general property of the brain isozyme, and similar inhibition 
studies were undertaken with the soluble rat brain hexokinase. 
The data shown in Pigs. 10 and 11 indicate, however, that 
UMP and UTP inhibition relative to ATP is noncompetitive. 
It thus appears that the allosteric site of the rat brain 
enzyme is not as specific. 
Effect of Hexokinase Modulators on the Soluble-Particu-
late Distribution of Brain Hexokinase Early studies on 
the mammalian hexokinases established that a large portion of 
the enzymatic activity is associated with the mitochondrial 
fraction of the cell (Utter, Wood, and Reiner, 1945; Meyerhof 
and Geliazkowa, 1947; Crane and Sols, 1953). The elegant 
studies of Rose and Warms (1967) on the release, rebinding, 
and location of mitochondrial hexokinases suggest that a 
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( I/ATP) xlO'^M 
Figure 10, Plot of reciprocal of initial velocity (v) versus 
reciprocal of molar concentration of ATP in the 
absence and presence of UMP 
Glucose concentration was maintained at 0.18 mM 
and ATP was varied in the concentration range 0.255 
to 2.30 mM. UMP concentrations are none (0), 15.0 
mM (V)/ and 30.0 mM (•). Other experimental 
details are described under "Experimental Proce­
dure . " 
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Figure 11. Plot of the reciprocal of initial reaction 
velocity (v) versus the reciprocal of the molar 
concentration of ATP in the absence and presence 
of UTP 
Glucose concentration was maintained at 0.15 mM, 
and ATP was varied from 0.22 mM to 2.00 mM. UTP 
concentrations were none (X), 1.6 mM (#) and 3.2 
mM (•). Other experimental details are described 
under "Experimental Procedure." 
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number of metabolites and inorganic ions affect the parti­
tioning of hexokinase into soluble and particulate activity 
pools. They found that glucose-6-P, ATP, ADP, and AMP can 
release the enzyme from the mitochondria. In addition, their 
experiments indicated that P^ could prevent the release of 
the enzyme by glucose-6-P, and that the extent of rebinding 
2+ 
of the enzyme to the mitochondria is affected by Mg . In 
similar studies with rat brain mitochondria, Wilson (1968) 
observed that ATP, ADP, and AMP can solubilize the enzyme 
in the presence of P^^, whereas the solubilization by glucose-
6-P is substantial only in the absence of P^. 
It was of interest to evaluate the ability of P^ and 
glucose-6-P to alter the soluble-particulate distribution in 
the presence of other hexokinase substrates and effectors. 
Furthermore, since particulate hexokinase preparations incu­
bated in the presence of such metabolites will redistribute 
into soluble and particulate activity pools, it was of inter­
est to establish how this distribution was altered in those 
experiments on the initial rate kinetics of soluble and 
particulate hexokinase in the presence of intracellular levels 
of substrate, product, and effector. Table 2 summarizes 
the effects of such metabolites on this distribution. 
Results of the first experiment indicate that increases in 
glucose-6-P concentration do not appreciably alter the 
distribution provided the other hexokinase substrates and 
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Table 2. Soluble-Particulate Distribution of Brain Hexo-
kinase Activity 
Experiments """S" 
% 
Experiment 1 
50 irM Tris-HCl (pH 7.6) 97 
Solution A® + no glucose-6-P 75 
Solution A + 0.1 mM glucose-6-P 66 
Solution A + 0.2 mM glucose-6-P 68 
Solution A + 0.4 mM glucose-6-P 68 
Solution A + 0.8 mM glucose-6-P 68 
Experiment 2 
50 mM Tris-HCl (pH 7.6) 98 
Solution + 10 mM P^ 84 
Solution B + 8 mM P^ 82 
Solution B + 6 mM Pf 79 
Solution B + 4 mM Pj^ 82 
Solution B + 2 mM Pi 77 
Solution B 76 
Experiment 3 
50 mM Tris-HCl (pH 7.6) 100 
0.1 mM glucose-6-P + 10 mM Pi 64 
0.1 mM glucose-6-P + 8 mM Pj_ 65 
0.1 mM glucose-6-P + 6 mM P^ 69 
0.1 mM glucose-6-P + 4 mM P^ 66 
0.1 mM glucose-6-P + 2 mM P^ 64 
0.1 mM glucose-6-P + 0 mM P^ 50 
10 mM Pi 81 
^Solution A contained 50 mM Tris-HCl, 4.4 mM ATP, 1.5 mM 
Mg2+, 0.75 mM ADP, 1.5 mM GTP, 1.3 mM UTP, and 9 mM P^. 
^Solution B contained 50 mM Tris-HCl, 4.4 mM ATP, 1.5 mM 
Mg2+, 0.75 mM ADP, 1.5 mM GTP, 1.3 mM UTP, and 0.15 mM 
glucose-6-P. Other experimental details are given under 
"Experimental Procedure." 
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effectors are present at their estimated intracellular 
levels. There is little effect even at glucose-6-P concen­
trations that far exceed what Dowry et al. (1964) found to 
exist in brain tissue. From the second experiment we find 
that does not alter the distribution. These data indicate 
that roughly 80% of the enzymatic activity remains associated 
with the mitochondrial fraction at 'physiological' effector 
levels. This is in good agreement with the observed vivo 
distribution (Johnson, 1960). The findings of the third 
experiment show that glucose-6-P can release slightly more 
than one-half of the hexokinase activity in the absence of 
the other metabolites used above. The glucose-6-P effect 
does appear to depend upon P^ level, but the effect is not 
completely abolished as 10 mM P^ can also solubilize some 
activity. 
It should be made clear that these data appear to be 
independent of mitochondrial concentration. In a companion 
experiment to those presented in Table 1, the percentage of 
bound enzyme was not changed when the mitochondrial concen­
tration was varied over an 8-fold range. This can be ra­
tionalized by the following equilibria. 
M + E = ME (6) 
ME + S = ES + M (7) 
where M, ME, E, S, and ES represent the concentrations of 
mitochondria, mitochondrial-enzyme complex, enzyme, substrate 
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and enzyme-substrate complex. The sum of these equilibria 
has no M or ME terms indicating that the solubilization 
process is independent of these factors. The assumption 
made here is that the substrate or effector mediates the 
solubilization by binding to the enzyme and not the mito­
chondria. Wilson (1968) has shown that glucose-6-P is a 
competitive inhibitor of ATP in the solubilization of hexo­
kinase. This is in agreement with the observation that 
glucose-6-P is also a competitive inhibitor with respect to 
ATP (Fromm and Zewe, 1962a; Copley and Fromm, 1967). The 
ability of glucose-6-P, ATP, ADP, and AMP to solubilize brain 
hexokinase parallels their respective Michaelis constants 
and inhibition constants. For these reasons it is attractive 
to consider that some change in the stability of the mito-
chondria-enzyme complex attends the binding of ligands to 
the enzyme. 
Initial Rate Kinetics of Soluble and Particulate 
Hexokinase in Presence of Intracellular Levels of Substrates, 
Products, and Effectors Earlier studies on the regulation 
of hexokinase investigated the regulatory roles of glucose-6-P, 
ADP, and P^ by utilizing a reconstructed segment of glycolysis 
(Uyeda and Backer, 1965a, b). In those studies the rate of 
formation of triose-P from glucose was measured by the oxida­
tion of DPNH in the presence of triose-P isomerase and 
44 
a-glycerol-P dehydrogenase. This segment of glycolysis in­
cludes the phosphofructokinase step which is known to be 
regulated by ATP, ADP, and P^ (Lowry, 1965; Uyeda and Backer, 
1965b). Furthermore, this segment does not permit studies at 
high glucose-6-P levels. The following experiments were 
carried out to further explore the direct effects of some 
glycolytic intermediates upon the hexokinase reaction. To 
our knowledge, this is the first attempt to evaluate these 
effects at approximate intracellular levels of these 
metabolites. 
The results presented in Figs. 12 and 13 permit the 
following preliminary conclusions. Pj^ can partially relieve 
the inhibition caused by glucose-6-P in the concentration 
range used. Inhibition by ADP, GTP, and DTP is not sensitive 
to changes in the P^ level. When the velocities of the 
reaction were estimated in the presence of each nucleotide, 
ADP, GTP, and UTP inhibited the rates by 26, 37, and 35%, 
respectively. In the presence of these nucleotides and 
glucose-6-P the rates of the hexokinase reaction are potently 
inhibited. Although these data were obtained at a glucose 
concentration of 1 yI4, similar depressions in the initial 
velocity were seen at 50 and 300 yM glucose. Finally, it is 
apparent that the stimulation caused by Pj^ is similar for 
both forms of the enzyme, suggesting that there is little 
functional difference between the soluble and particulate 
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Figure 12. Plot of initial velocity (v) versus molar 
concentration of 
Glucose (including 10^ cpm ^^C-glucose), ATP, 
2+ 
Mg , and Tris-HCl (pH 7.6) were maintained at 1 
|iM, 4.35 raM, 1.5 mM, and 50 mM, respectively. 
14 
Velocities were measured by C-glucose-6-P pro­
duced in the absence of any additional components 
(A), in the presence of 0.15 mM glucose-6-P (#), 
0.75 mM ADP, 1.5 mM GTP, 1.3 mM UTP (V) , and 0.15 
mM glucose-6-P, 0.75 mM ADP, 1.5 mM GTP, and 1.3 
mM UTP (•). Reaction mixtures (0.5-ml) were ini­
tiated with addition of particulate brain hexo-
kinase which was adjusted to give initial rates 
and later corrected to constant enzyme concentration. 
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Figure 13. Plot of initial velocity Cv) versus molar 
concentration of P. for soTuble rat brain hexo-
kinase 
Reaction conditions were identical with those 
described in the legend to Figure 12, and veloc­
ities were determined in the absence of any 
components (•), in the presence of glucose-C-P 
(#), ADP, OTP, and UTP (#), and glucose-6-P, 
ADP, GTP, and UTP (A) . 
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Figure 14. Plot of initial velocity (v) against Mg (as 
mgs04) 
Each reaction mixture contained 50 uM glucose, 
4.4 mM ATP, 0.1 mM TPN+, 50 mM Tris-HCl (pH 7.6), 
and a variable amount of MgSO^. Velocities were 
measured in the absence (•) and presence of 0.75 
r# ADP, 1.5 mM GTP, and 1.3 mM UTP (*•). Other 
experimental <5e+"-ailR are described under 
"Experimental Procedure." 
48 
enzymes. 
The findings presented in Fig. 14 show that the nucleo­
tide inhibition by ADP, GTP, and UTP remains substantial at 
2+ 
higher levels of Mg . These data further suggest that the 
2+ 
inhibition does not arise solely from the binding of Mg 
to these nucleotides. 
Effect of Mg^* and MgATP^ on Brain Hexokinase In 
a recent report Bachelard described the allosteric activation 
of brain hexokinase by Mg^^ and MgATP^ (Bachelard, 1971b). 
He found that substrate-saturation curves of brain hexokinase 
for MgATP ~ were sigmoidal at subsaturating levels of glucose 
2+ 
when the Mg^^^^i/A^^total ^ ^^io was unity. On the other 
hand, he observed that these saturation curves were strictly 
hyperbolic in the presence of excess magnesium ion (i.e., 
Mg^^tai/^^^total = 5). Hill plots of these data indicated 
that the number of binding sites for MgATP varied from 1.05 
to 1.8 depending upon the magnesium ion concentration. In 
addition, the sigmoidicity and deviation from Michaelis-
2+ 
Menten kinetics at a Mg^otal^^^^total 1*0 became less 
pronounced with increasing glucose concentration. Finally, 
he found that although substrate-saturation curves for 
2+ 
glucose were hyperbolic when Mg^otal^^^^total unity, 
reciprocal plots were slightly nonlinear. Bachelard inter­
preted these results to reflect homotropic cooperative 
binding of MgATP^ to brain hexokinase and postulated that 
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acts at a topologically distinct activator site at low 
2+ 
MgtQtal/^"^^total ratios but acts as an inhibitor whenever 
this ratio exceeds 5. 
Examination of Bachelard's data suggests that there is 
an alternative interpretation fully in agreement with his 
experimental data but in harmony with previous studies in 
which no evidence for such complex binding of MgATP^ was 
obtained (Copley and Fromm, 1967; Ning, Purich, and Fromm, 
1969; Purich and Fromm, 1971). This reinterpretation, which 
2-does not require postulating cooperative MgATP binding or 
2+ 
the presence of a distinct activator site for Mg , considers 
4-
the presence of large quantities of ATP that arise whenever 
2+ 
Mgtotai/^^^total near unity. Furthermore, it is also 
possible to rationalize the glucose effects on the sigmoi-
dicity and deviation from Michaelis-Menten kinetics at low 
magnesium ion concentrations. Changes in the Hill coefficient 
9-» 94-
for MgATP " binding at different M^total'^^'^^total f&tios are 
explained, and a discussion of the applicability of the Hill 
equation in velocity studies of multisubstrate cooperative 
enzyme systems is presented. These studies serve to suggest 
that there is no allosteric involvement of Mg^^ or MgATP^ in 
the brain hexokinase reaction, but that the level of free 
2+ 
uncomplexed Mg in cerebral tissue may play an important 
role in the regulation of the phosphorylation of glucose by 
adjusting the concentration of MgATP^" and ATP^~. 
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2+ 
Bachelard explored the possibility that Mg is involved 
in the hexokinase reaction in a fashion distinct from its 
role as MgATP by examining the initial reaction velocity 
dependence upon MgATP^ at ratios of 1.0 
and 5.0. While the velocity dependence in the presence of 
2+ 
excess Mg appeared to be strictly hyperbolic, sigmoidal 
2+ 
responses were observed at the lower Mg levels. In view 
of the fact that all known nucleoside di- and tri-phosphate 
dependent phosphotransferase reactions require a divalent 
metal ion to combine with the nucleotide to form the active 
substrate (Cohn, 1969), it became of interest to determine 
the percentage of ATP^^^^^ chelated with magnesium ion under 
2+ 
the conditions used by Bachelard. When the Mg^otal^^^^total 
ratio was 1.0, the percentage of ATP^^^^^ present in solution 
as MgATP^ varied with the extent of dilution. For instance, 
2+ 
the concentration of and ATP^^^^^ varied from 0.05 mM 
to 0.8 mM in the experiment presented in Fig. lb of 
Bachelard's report. If one assumes that the stability 
2"" 
constant for the MgATP complex in 0.15 M triethanolamine-
HCl buffer (pH 7.6) is 73,000 M ^ (0'Sullivan and Perrin, 
1964; Bachelard, 1971b), then the concentration of MgATP^ 
will vary from 0.03 mM to 0.71 mM. Thus considerable 
correction is necessary for the abscissa values presented in 
Fig. lb of Bachelard's report. Since the correction is more 
substantial at the lower end of this concentration range, it 
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appeared that such effects might well explain the sigmoidal 
curvature that he observed. When such corrections were made 
on photographic enlargements of Fig. lb of Bachelard's paper, 
the rather normally hyperbolic saturation curves shown in 
Fig. 15 were observed. For the sake of clarity, only the 
corrected curves are presented. 
Additional corrections also were possible for the data 
presented by Bachelard. For example, at pH 7.6 approximately 
18.3% of is present as the protonated species, 
HATP^~, if one assumes that HATP^" has a pK^ of 6.95 (Smith 
and Alberty, 1956). The stability constant for the MgHATP^ 
complex is approximately 31 M ^ CSmith and Alberty, 1956), 
and it is quite unlikely that very much of the HATP^ is 
4-
present as its magnesium ion complex. Furthermore, ATP is 
a potent inhibitor of yeast and brain hexokinases (Rudolph and 
Fromm, 1971; fJing, Purich, and Fromm, 1969; Bachelard and 
Goldfarb, 1969; Purich and Fromm, 1971). Corrections for 
3- 4-
HATP and ATP were not made as the deviations from hyper­
bolic velocity responses observed by Bachelard seem fully 
accountable in terms of the correction made in Fig. 15 alone. 
Bachelard attempted to illustrate more clearly the 
departure from Michaelis-Menten kinetics by comparing plots 
of [MgATP 3/v versus {MgATP ] at several magnesium ion 
n I 
levels. Again, in the presence of low Mg^^ he found marked 
curvature in these plots. If one corrects these data as 
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Figure 15. Plot of velocity (v) versus the [MgATP] for brain 
hexokinase at a M^total'^^'^^total ^^^io of 1.0 
Glucose concentrations were 0.1 mM (0), 0.05 mM (#), 
0.035 mM (D) , and 0.025 mM (•). The velocity 
measurements are those of Bachelard (1971b) and 
the MgATP^ concentrations on the abscissa were 
corrected for the concentration dependence of the 
2— 
MgATP complex. Corrections were made directly 
upon photographic enlargements of Bachelard*s data 
as described under "Experimental Procedure." 
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described in the legend to Fig. 15 the curvature of such 
plots is far less pronounced as shown in Fig. 16. It should 
be noted that corrections of Fig. 2b of Bachelard's report 
requires large changes in the values plotted on both the 
ordinate and the abscissa. The uncorrected and corrected 
plots are shown in Fig. 16. Although the curves remain 
somewhat nonlinear, one must note that no corrections were 
4-
made for ATP inhibition. 
In his studies of the effects of Mg and MgATP on 
the kinetic properties of brain hexokinase, Bachelard 
observed that nonlinear velocity versus MgATP^" plots 
became less pronounced at elevated glucose concentrations 
and was apparently absent at saturating levels of glucose 
(Bachelard, 1971b; Bachelard and Goldfarb, 1969). In a 
companion experiment, Bachelard observed that plots of 
[glucose]/v versus [glucose] were linear in the presence of 
2+ 2+ 
excess Mg , but slightly curved when the ratio of 
to total I'O (Bachelard, 1971b) . While Bachelard 
interprets these results to suggest that alterations in the 
conformation of the MgATP^ -binding sites may affect the 
conformation of the glucose-binding site, a much simpler 
explanation can be offered in terms of the kinetic reaction 
mechanism of brain hexokinase action. 
As stated earlier, the kinetic mechanism appears to be 
of the sequential random type for rat and bovine brain 
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Figure 16. Plots of [MgATP ]/v versus [MgATP ] for brain 
2+ 
hexokinase at a M^total'^^^^total of 1.0 
2_ 
MgATP was varied in the range from 0.05 mM to 
0.6 mM, and the glucose concentration was main­
tained at 0.1 mM (0), 0.05 mM (#), 0.035 mM (•) , 
and 0.025 mM (•) . Reaction rates are expressed 
as OD^^g/min. Plot A is the uncorrected data of 
Bachelard (1971b), and Plot B is corrected for the 
2"" 
concentration dependence of the MgATP " stability 
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hexokinase, and it is generally assumed that all substrates 
bind rapidly relative to the interconversion of the produc­
tive ternary complex. This has been independently confirmed 
by the use of approaches similar to those outlined on pages 
26 and 27 (Bachelard, Clark, and Thompson, 1971). In 
addition, the uncomplexed form of ATP acts as a linear 
2 _  
competitive inhibitor with respect to MgATP for these 
mammalian enzymes (Ning, Purich, and Fromm, 1969; Purich and 
Promm, 1971), whereas studies from Bachelard's laboratory 
appear to indicate 'mixed' inhibition (Bachelard and 
Goldfarb, 1969). The latter observation can be better under-
4-
stood if one considers the levels of ATP used in the 
experiments of Bachelard and Goldfarb. They observed rela­
tively small intercept changes in Lineweaver-Burk type plots 
4-(Lineweaver and Burk, 1934) at the higher levels of ATP 
which correspond to levels that are from 11.3 to 17.5-fold 
higher than the dissociation constant for this inhibitor 
(Bachelard and Goldfarb, 1969). At such high levels of the 
free uncomplexed ATP, it is possible that these small inter­
cept changes could result from a weak nonspecific binding 
not related to the mode of binding at lower inhibitor concen­
trations where their data appear to suggest competitive 
inhibition. If we grant that ATP^ is indeed a competitive 
inhibitor of the brain enzyme, then the following scheme 
outlines the various interactions of substrates and ATP*" 
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with this phosphotransferase; 
E-ATP 
E-MgATP 
2-
k. 
.2-
E-MgATP -glucose- -4 products 
K 4 
E-glucose 
kii 
E-glucose-ATP 4-
The rate expression for the above kinetic mechanism can be 
expressed in the following form: 
V = 
V. 
m ( 8 )  
k, 
1 + 1 + 
kii 
K-
B 
% 
AB 
1 + 
K .  
where v, A ,  B ,  and I represent initial reaction velocity, 
2 -  4-
maximal velocity, MgATP , glucose, and ATP , respectively. 
The various K's are dissociation constants defining the 
equilibria described in the scheme. If or ^ K^, 
increasing the glucose concentration will make the AB term 
in the denominator smaller and thereby lessen the inhibition 
by ATP^ . At the total of 1, there is a 
relatively high level of uncomplexed ATP^" at the most dilute 
tot&l ' cliasu ulic cwliol&ai u j-fcvwillcs jlcsa & lix j. xoali l. ab uiic 
concentration of ATP^^^^g^ increases. These considerations 
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therefore explain why one would observe an interdependence 
2 ^  o I  
between the binding of MgATP " and glucose at the lower Mg 
level. In a similar manner, one can understand why 
[glucose]/v versus [glucose] plots are slightly curved at 
suboptimal amounts of the divalent cation. Although we 
believe that ATP*" inhibition is competitive, it may be 
important to note that similar arguments could also be made 
if the inhibition were 'mixed'. 
On the basis of Hill (1913) plots, Bachelard has stated 
2"" 
that the number of binding sites for MgATP ~ on brain hexo-
kinase is 1.8 at a Mgtatal/^^^tatal of unity, and 1.0 
in the presence of excess magnesium ion. Here again, correc­
tions for the large percentage of total ATP that exists as 
4-
the uncomplexed ATP and for the inhibitory action of this 
species suggest that the Hill coefficient at high and low 
2+ 
Mg is near unity (i.e., n < 1.25). 
Finally, one additional point should be made regarding 
2+ 
the differences in the observed maximal velocity at 
4-
ATP^Q^^^ ratios of 1.0 and 5.0 in Bachelard's study of the 
velocity dependence of the hexokinase reaction upon MgATP 
(Bachelard, 1971b). From Fig. 4 of his report, it seems clear 
2+ 
that the excess Mg inhibits the enzyme and may account for 
the lower maximal velocities at ^ ^total'^^^^total of 5.0. 
Responses of Brain Hexokinase to the Adenylate Energy 
Charge The concept that biosynthetic and biodegradative 
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reactions are sensitively responsive to changes in the 
adenylate energy charge of the cell has rapidly gained favor 
in recent years. The original proposal of Atkinson and 
Walton (1967) suggested that energy charge be formally 
defined as one-half the number of anhydride-bound phosphates 
per adenosine moiety (i.e., energy charge = [(ATP) + %(ADP)]/ 
[(AMP) 4- (ADP) + (ATP)]). Atkinson has argued that the 
adenylate energy charge represents an appropriate input 
parameter in the control of individual enzymes and metabolic 
sequences that utilize or regenerate ATP (Atkinson, 1968). 
The energy charge model assumes that enzymes have evolved to 
respond to the over-all state of the adenine nucleotide pool 
rather than to concentration changes of any single species 
within it, so that a clearer understanding of the vivo 
control of enzymes and metabolism will be obtained by study­
ing this over-all response, rather than the response to AMP, 
ADP, or ATP, separately. At present, the response of a 
number of diverse enzyme systems ^  vitro has been evaluated 
(Klungs^yr, Hagemen, Fall, and Atkinson, 1968; Shen, Fall, 
Walton, and Atkinson, 1968; Atkinson and Fall, 1967; Shen 
and Atkinson, 1970). Basically, these studies have monitored 
the response of initial reaction velocity to alteration in 
the energy charge, assuming that the distribution of the 
adenylates is governed by the mass action ratio of the aden­
ylate kinase reaccioa. Oiily one study has attempted to 
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consider the importance of evaluating these responses under 
conditions that reasonably reflect intracellular conditions 
(Villar-Palasi and Wei, 1970). 
Studies from several laboratories have indicated that 
the mammalian hexokinases are quite sensitive to inhibition 
by glucose-6-P and ADP (Crane and Sols, 1953; Weil-Malherbe 
and Bone, 1951). Recent studies from our laboratory suggest 
that ADP and several other nucleotides can severely inhibit 
rat brain hexokinase under simulated intracellular conditions 
CPurich and Fromm, 1971). Rapoport et al. (Rapoport, 
Hinterberger, and Hofmann, 1961) first proposed that hexo­
kinase represented the pacemaker in red cell glycolysis. 
More recent studies have confirmed this proposal and have 
described the role of glucose-6-P in this process (Rose and 
O'Connell, 1964). We felt that it would be useful to test 
the responses of these enzymes under conditions that approxi-
2+ 
mate the intracellular level of substrates, Mg , and adeny­
lates. Considering the potent inhibition of hexokinases by 
4-
ATP described earlier, it appeared that magnesium ion 
levels might play an important role in enzyme responses to 
energy charge. The data presented in Fig. 17 indicate that a 
wide spectrum of responses can be obtained depending on the 
Mg^^ level. It is clear that the responses observed at 
intracellular levels of magnesium ion do not resemble the 
generalized response of an ATP-utilizing system as described 
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by Atkinson (1968) . 
Since it is likely that, for nearly all enzymic reactions 
under normal physiological conditions, there are finite 
levels of all reaction substrates and products, it was felt 
that the inhibitory effects of the nonadenylate reaction 
product should thus be considered in evaluations of the 
sensitivity of brain hexokinase to alteration in the energy 
charge. Product effects can be especially critical for 
kinetically reversible enzymes since the net reverse reaction 
can also take place over the range of energy charge used. 
The ease with which one can accurately experimentally evalu­
ate energy charge responses in the presence of all substrates 
and products, however, depends largely upon the physical and 
kinetic properties of the enzyme catalyzed reaction under 
study. Ideally, one could monitor a spectral change due to 
the net conversion of substrate to product as with the 
pyridine-linked dehydrogenases, in the absence of such 
optical changes during the reaction, one may encounter some 
experimental difficulties in measuring such responses. For 
example, in experiments measuring the activity of yeast 
hexokinase (which is readily reversible) in the presence of 
all reaction substrates and products, one must take care to 
measure the rate of the net phosphorylation of glucose as 
opposed to the rate of a particular exchange reaction, TO 
make this distinction, one may simultaneously measure both 
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Figure 17. Plot of initial reaction velocity (expressed as 
ZkOD24o/niiii) catalyzed by soluble brain hexokinase 
versus energy charge 
Each reaction mixture contained a total of 5.5 mM 
adenylates as AMP, ADP, and ATP in sufficient 
quantity to satisfy the desired energy charge and 
an adenylate kinase mass action ratio of 0.8, 50 
mM Tris-HCl CpH 7.6), 20 mM potassium chloride, 50 
yM glucose, 60 )iM TPN^, excess glucose-6-P dehydro 
2+ 2+ 
genase, and 1.5 mM Mg C#X, 5.5 mM Mg Cf) , and 
25 mM Mg^^ (A). Other experimental details are 
presented under "Experimental Procedure." 
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14 
the rate of incorporation of C-glucose into the glucose-
32 
6-P pool and the rate of incorporation of P-glucose-6-P 
into the ATP pool. The difference between these rates 
defines the rate and direction of the net reaction. This 
procedure would be necessary for any enzymic reaction for 
which the V^/V^ ratio is relatively low. One may obviate 
this difficulty by using an enzyme which is essentially 
irreversible such as the brain hexokinase for which the V^/V^ 
ratio is approximately 13,200 at pH 7.6 (Rudolph and Fromra, 
1971). For this latter hexokinase, except at thermodynamic 
equilibrium, the rate of the reverse reaction is negligibly 
small in comparison to the forward reaction rate, and the 
net reaction is measurable to well within experimental error 
14 by the rate of C-glucose incorporation into the glucose-
6-P pool. The findings presented in Fig. 18 indicate that 
glucose-6-P at its approximate intracellular level (Dowry 
and Passonneau, 1964) alters the energy charge response of 
soluble rat brain hexokinase under approximate ^  vivo levels 
2+ 
of glucose and Mg . The response in the absence of glucose-
6-P measured by the radioactive assays used in these studies 
is similar to the response previously measured by coupling to 
glucose-6-P dehydrogenase. These data also suggest that the 
enzyme is relatively insensitive to the energy charge in the 
absence of reaction product and becomes even less sensitive 
in its presence. 
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Although one might reasonably argue that the adenylates 
are directly concerned with most energy utilizing and produc­
ing reactions, one must also consider the approximately 40% 
of the total cellular nucleoside-5'-triphosphates are not 
adenylates in such widely different sources as rat brain 
tissue CLowry et / 1964) or Escherichia coli (Dowry et al., 
1971). These compounds are also important in view of their 
potential action as competitive inhibitors or weak alterna­
tive substrates of many phosphotransferase catalyzed reac­
tions. It was of interest to investigate the effect of 
approximately intracellular levels of such nonadenine 
nucleotides on the response of rat brain hexokinase to the 
adenylate energy charge. The findings presented in Fig. 19 
suggest that the presence of these nucleotides serves to 
further suppress the noticeably insensitive response of this 
enzyme to changes in the adenylate charge. This observation 
suggests that, if increases in the adenylate energy charge 
are accompanied by increases in the energy charge of the 
nonadenylates through the nucleoside diphosphate kinase 
reaction (Thompson and Atkinson, 1971), then some ATP-utiliz-
ing reactions will become more inhibited by the nonadenine 
nucleoside di- and tri-phosphates as the charge increase. 
Such action would not be consistent with the adenylate charge 
hypothesis which predicts acceleration of ATP-utilizing 
reactions at high energy charge. 
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Figure 18. Plot of the initial reaction velocity (v) versus 
the energy charge in the absence (A) ancT presence 
(V) of 0.15 mM glucose-6-P 
Each reaction mixture also contained 50 mM Tris-
HCl (pH 7.5), 40 uM glucose (including approxi­
mately 100,000 cpm of ^^C-glucose), 5,5 mM adenine 
nucleotides, and 2,5 mM MgCl2. The adenylate 
distribution was determined as described in the 
legend to Fig. 17. Reactions were initiated by 
the addition of soluble rat brain hexokinase and 
were incubated for a period of 20-60 min, over 
which period the reaction rate was constant. 
Samples were quenched and processed as described 
under "Experimental Procedure." 
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Figure 19. Plot of the initial velocity (v) of the rat brain 
hexokinase reaction versus the energy charge in 
the absence {•) and presence (A) of GTP and UTP 
Each reaction mixture contained 50 mM Tris-HCl 
(pH 7.5)/ 40 yM glucose (including 108,000 cpm of 
^^C-glucose), 5.5 mM adenine nucleotides, 2.5 mM 
MgClg, 1.5 mM GTP, and 1.3 mM UTP. Other experi­
mental details are described in the legend to 
Fig. 18 and under "Experimental Procedure." 
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GENERAL DISCUSSION 
The results of the kinetic experiments on soluble rat 
brain hexokinase described herein support in general the 
recent kinetic studies of bovine brain hexokinase by Ning, 
Purich, and Fromm (1969) . These investigators had concluded 
that solubilized bovine brain hexokinase has a random Bi Bi 
kinetic mechanism in which all steps equilibrated rapidly 
2-
relative to the interconversion of the enzyme MgATP glucose 
and enzyme MgADP^ glucose-6-P ternary Michaelis complexes. 
They also found that the enzyme was allosterically inhibited 
by the reaction product, ADP, and other purine nucleoside-5'-
mono-, di-, and tri-phosphates. The studies of Ning, Purich, 
and Fromm (1969) were carried out on an enzyme which during 
the course of purification and solubilization from the outer 
mitochondrial membrane was subjected to the possibly desensi­
tizing action of deoxycholate, Triton X-100, and a-chymotryp-
sin (Schwartz and Basford, 1967). The present studies, 
however, have employed a hexokinase preparation from the 
soluble rat brain fraction (Grossbard and Schimke, 1966), 
thereby obviating the use of such agents. This enzyme appears 
to be identical to the Triton X-100 solubilized rat brain 
hexokinase based upon starch block electrophoresis (Wilson, 
1D67) . Ir. addition to the use of a soluble hexokinase.- the 
present studies differ from previous studies (Copley and 
Fromm, 1967; Ning, Purich, and Fromm, 1969) which did not 
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attempt to evaluate the regulatory potential of a number of 
modulators that have been postulated to have specific effects 
on brain hexokinases or general effects on transphosphoryl-
ases. 
Although the methodology and limitations of the experi­
mental approaches used in these studies have been discussed 
in some detail, it may be of value to further qualify some 
of the conclusions drawn in these studies. Moreover, it may 
be of particular value to outline the manner in which rat 
brain hexokinase may be regulated vivo based upon these 
in vitro experiments. 
There is now ample evidence supporting the contention 
that the kinetic mechanism of brain hexokinase involves a 
random interaction of enzyme and substrates. The possibility 
that the kinetic mechanism is ordered with glucose acting as 
the obligatory first substrate has been ruled out on the 
basis of the following evidence. The product which corres­
ponds to the first substrate in an ordered mechanism should 
act as a competitive inhibitor with respect to that substrate 
(Alberty, 1958). Several laboratories, however, have indi­
cated that glucose-6-P is a competitive inhibitor of ATP and 
a mixed inhibitor of glucose CGrossbard and Schimke, 1966; 
Copley and Fromm, 1967), and that ADP is a mixed inhibitor 
of both substrates (Hanson and Fromm, 1965; Grossbard and 
Schimke, 1966; Copley and Fromm, 1967; Ning, Purich, and 
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Froinin, 1969) . Furthermore, the use of alternative substrates 
has also served to exclude this possibility. If the kinetic 
reaction mechanism were ordered with glucose adding first, an 
alternative substrate of glucose would appear to act like a 
competitive inhibitor of glucose, and inhibition relative 
to ATP would be nonlinear concave upward when plotted as 
velocity"^ versus ATP ^ (Fromm, 1964; Rudolph and Fromm, 1971). 
Past reports have demonstrated that mannose does, indeed, act 
like a competitive inhibitor of glucose, but it is a mixed 
inhibitor of MgATP^~ when the initial reaction velocity was 
measured as a function of glucose-6-P production which is 
monitored by use of the specific yeast glucose-6-P dehydro­
genase (Hanson and Fromm, 1965; Copley and Fromm, 1967; Ning, 
Purich, and Fromm, 1969). The ordered mechanism described 
above has also been eliminated from consideration by the use 
of competitive inhibition studies presented in this report. 
Finally, the possibility that ATP is the leading substrate 
in an ordered ternary complex mechanism exists only for the 
case where its product is considered to glucose-6-P and not 
ADP. Considering that yeast hexokinase operates with a random 
kinetic mechanism (Fromm and Zewe, 1962a; Fromm, 1968; Rudolph 
and Fromm, 1971), this possibility appears remote. The random 
mechanism therefore appears to be the only likely kinetic 
mechanism that reconciles all the kinetic findings of the 
mammalian brain enzyme. 
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The present studies indicate that the existence of a 
distinct allosteric inhibitory nucleotide site may be a common 
feature of the rat and bovine brain enzymes (Ning, Purich, and 
Fromm, 1969; Purich and Fromm, 1971). The experiments on ADP 
inhibition at saturating levels of either substrate have given 
qualitatively identical results for the soluble cytoplasmic 
rat brain enzyme and the Triton X-100 solubilized bovine brain 
hexokinase. These enzymes do differ, however, with respect to 
the apparent nucleotide specificity of the inhibitory site. 
For the brain enzyme, only purine nucleotides bind at the 
allosteric site, as indicated by the observation that pyri-
midine nucleotides act as linear competitive inhibitors 
relative to ATP (Ning, Purich, and Fromm, 1969). On the other 
hand, both pyrimidine and purine nucleotides appear to bind 
at the allosteric site on the rat brain enzyme. It should be 
noted that no attempt has been made to carry out equilibrium 
binding studies of the ADP interaction with the brain enzyme. 
The amount of purified hexokinase that can be obtained pre­
cludes use of binding studies at present. For example, with 
the method of Grossbard and Schimke (1966), one would require 
approximately 500 rat brains (average weight, 1.6 g) to obtain 
3 mg of hexokinase with a final specific activity of 80 units/ 
mg. Assuming a dimer molecular weight of 10^ g (Grossbard and 
Schimke, 1966), this amount would represent less than 6 x 10~° 
moles of hexokinase active or allosteric sites. Moreover, 
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reliable equilibrium binding data would be difficult to obtain 
in view of the fact that the ADP binding constant is less than 
10^ for the enzyme ADP complex as estimated from inhibi­
tion studies (Grossbard and Schimke, 1966; Hanson and Fromm, 
1965; Purich and Fromm, 1971). 
An alternative explanation of the noncompetitive nature 
of the ADP inhibition of ascites tumor hexokinase has been 
presented by Kosow and Rose (1970). They suggest that the 
interconversion of the ternary complexes in the random mecha­
nism may not be rate limiting and that glucose-6-P release 
may, in fact, be the slowest step in the process. Kosow and 
Rose (1970), therefore, favor the possibility that the effect 
of ADP on the maximal velocity (i.e., the intercept effects in 
Lineweaver-Burk type plots of ADP inhibition data) must result 
from ADP interacting at the ADP product site on the enzyme-
glucose-6-P binary complex. Their proposal is based, in part, 
upon the fact that the ADP*-»ATP equilibrium exchange rate 
exceeds the glucose'—rglucose-e-P equilibrium exchange rate in 
the yeast hexokinase reaction (Fromm, Silverstein, and Boyer, 
1964). The analogous experiments have not been carried out 
for mammalian hexokinases since the ratio of the maximal 
velocities of the forward and reverse reactions is very large 
(Purich and Fromm, 1972b) . Their proposal does not, however, 
^ ^ ^ A *4*^3 m Ai» » 1^ m « «a» 1» m «m M M m m 
ADP and cannot apply to the bovine brain enzyme (Ning, Purich, 
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and Fromm, 1969). It is also of interest to note that Coffee 
and Hu (1972) have found that our analysis (Ning, Purich, and 
Froiran, 1969; Purich and Froinin, 1971) does fully account for 
the ADP inhibition of a pseudomonad gluconokinase. They found 
that plots of (1/velocity) versus ADP were linear, suggesting 
that ADP bound at two sites on the enzyme. 
It was the complex nature of the ADP inhibition of the 
mammalian brain hexokinases that focused our attention upon 
the regulatory role of nucleotide inhibition. Although the 
kinetic studies on the order of substrate addition and ADP 
inhibition suggested a regulatory role for nucleotide inhibi­
tion, the levels of substrates, products, metal ions, and 
hexokinase effectors used in such studies, are not representa­
tive of the conditions thought to exist within the cell (Lowry 
et al., 1964; Mcllwain, 1966). This is especially true for 
the concentration of free uncomplexed magnesium ion which is 
generally maintained at a fixed optimal level in kinetic 
studies but is variable in the cell. The best current esti­
mates of the magnesium ion concentration in rat brain place 
the normal intracellular level in the range of 1.5 mM to 
3.5 mM (Bachelard and Goldfarb, 1969), considerably below 
optimal. Re-evaluation of the rates of glucose phosphoryla­
tion under simulated intracellular conditions has served to 
demonstrate that glucose-6-P, P^, ADP, and other nucleotides 
may regulate brain hexokinase. Inhibition caused by glucose-
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6-P was found to be somewhat sensitive to changes in thé 
level with greatest sensitivity in the concentration range 
corresponding to the intracellular P^ content (Lowry et ad., 
1964; Mcllwain, 1966). ADP inhibition was found to be P^-
insensitive over the P^ range examined. Under conditions 
corresponding to the content of glucose-6-P, P^, ADP, GTP, 
and UTP, the cumulative inhibition of brain hexokinase amounted 
to 95-97%, and there was little difference between the soluble 
and particulate responses to P^. This inhibition corresponds 
rather favorably with estimates of the ^  vivo inhibition of 
hexokinase (Lowry and Passonneau, 1964). 
The P^ stimulation of glucose-6-P-inhibited brain hexo­
kinase may arise from a number of mechanisms. Since P^ has no 
apparent effect on the velocity of the uninhibited reaction 
rate, P^ stimulation of glucose-6-P-inhibited brain hexokinase 
is a deinhibition rather than an activation. In this regard, 
P^ deinhibition is analogous to the AMP, ADP or 3',5'-cyclic 
AMP mediated deinhibition of ATP-inhibited rabbit skeletal 
muscle phosphofructokinase (Mansour, 1972). It is of interest 
to note that, although both ATP and glucose-6-P appear to bind 
at the same locus on the enzyme (Fromm and Zewe, 1962a; Copley 
and Fromm, 1967; Grossbard and Schimke, 1966), P^ has no 
effect on the Michaelis constant for ATP. In fact, the 
Michaelis constants for glucose and ATP were identical to 
within experimental error in the absence and presence of 
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15 mM (Purich and Froinm, 1971) . Nevertheless, our experi­
ments indicate that under simulated intracellular conditions 
both products are quite effective as inhibitors with glucose-
6-P inhibition depending inversely upon the cellular P^ 
content. 
The potent inhibition by intracellular levels of GTP, 
UTP, and ADP should not be attributed merely to a trivial 
4-
mechanism involving competition with ATP for the available 
2+ 
Mg . On the contrary, our data suggest that at higher levels 
2+ 
of Mg the inhibition is even more appreciable. This would 
be anticipated if the metal-nucleotide complexes bound more 
tightly to the inhibitory nucleotide site than do the free 
nucleotides. Although it is certain that these compounds will 
bind a significant amount of the magnesium ion, the amount of 
this divalent cation associated with each metal-nucleotide 
2+ 
species will remain quite constant as long as the total Mg 
concentration does not exceed the total nucleotide concentra­
tion and the ratio of total nucleotide remains constant. This 
is apparent from considerations of the stability constants for 
these complexes. Therefore, any error in the value of avail­
able nonparticul^te intracellular magnesium ion will not be 
of major consequence so long as the value does not exceed 7 mM. 
From the range of values estimated for this metal ion in brain 
tissue (Bachelard and Goldfarb, 1969), this possibility appears 
to be remote. 
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The nature of the ADP inhibition and the fact that hexo-
kinase can be considered as the first committed step in brain 
glycolysis had suggested that brain hexokinase may be influ­
enced strongly by the adenylate energy charge. The energy 
charge is considered by proponents of the concept to be of 
central importance in the regulation of all reactions uti­
lizing or re-supplying ATP (Atkinson, 1968; Atkinson and 
Walton, 1967). The studies described in this report indicate 
that rat brain hexokinase does not respond as predicted by 
the energy charge model. A number of factors were found to 
influence the response of phosphotransferases to the adenylate 
energy charge. The responses of human erythrocyte hexokinase 
and pyruvate kinase, rabbit skeletal muscle pyruvate kinase 
and phosphofructokinase, and yeast hexokinase all appear to be 
markedly affected by a number of experimentally adjustable 
factors. These include; a) the free uncomplexed magnesium 
ion concentration, b) total adenylate concentration, c) pH, 
d) the adenylate kinase mass action ratio, e) the non-adenine 
nucleotide substrate and product levels, f) the size and 
composition of the nonadenine nucleotide pool, and g) the 
kinetic reaction mechanism of the enzymic reaction under study 
(Purich and Fromm, 1972d). The studies with rat brain hexo­
kinase served as the basis for the first theoretical and 
practical quantitative appraisal of the adenylate, energy 
charge model (Purich and Fromm, 1972d). The results of these 
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studies suggest that the use of the energy charge index, 
[ (ATP) + 3S(ADP) 3/1 (ATP) + (ADP) + (AMP)], to describe the 
basic control of energy metabolism is very incomplete, and 
it remains to be convincingly demonstrated that this parameter 
plays an important ^  vivo role. 
It now appears that hexokinase regulation results from 
the interplay of several factors, and that, in brain, it is 
coordinated with the phosphofructokinase reaction to provide 
for effective glycolytic control. A schematic model for this 
coordination is shown in Fig. 20. The kinetics of glucose 
transport in cerebral cortical tissue argue strongly that 
the intracellular level of glucose is really quite low and 
that nearly all of the transported glucose is promptly 
phosphorylated (Bachelard, 1971a). The transport of glucose 
into the tissue has been shown to be a saturable carrier-
mediated form of active transport (Fishman, 1964; Crone, 1965) 
and may prove to be an important control point responding to 
changes in metabolite and hormonal levels. Bachelard has 
suggested that the rate of glucose permeation may, at times, 
even be the rate limiting step in the utilization of glucose 
(Bachelard, 1970). The studies of Uyeda and Racker (1965b) 
and those presented here suggest that glucose-6-P serves as 
an effective regulator and is also sensitive to changes in 
the P^ level. It seems clear that, since glycogen storage in 
brain is quite low (Bachelard and Mcllwain, 1969), in the 
76 
EXTERNAL GLUCOSE 
Blood-Brain Barritr 
GLUCOSE 
UTRGTP 
ana other 
NudsotidM 
ADP 
GLUCOSE-6-P' -X 
>1 
Ff»UCT0SE-6-P, 
1 ©' 
adp'' 
ADP, AMP, and 
^FRUCT0SE-l,6-dlP 3',5'-cyc«cAMP 
v 
0 ACTIVATION 
0 INHIBITION 
e DE INHIBITION 
Figure 20. Schematic representation of the coordinated 
control of the reactions catalyzed by brain 
hexokinase and phosphofructokinase 
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absence of deinhibition of hexokxnase a rise in the 
level would affect the rate of the phosphofructokinase reac­
tion both positively (by lowering the for fructose-6-P) 
and negatively (by lowering the intracellular level of 
glucose-6-P and fructose-6-P) . The Pj^ deinhibition of 
glucose-6-P-inhibited brain hexokinase appears to permit 
the rate of glycolysis to increase by permitting the rapid 
phosphorylation of glucose at moderate levels of glucose-6-P 
and fructose-6-P. Our present studies point to a multivalent 
inhibition of hexokinase involving glucose-6-P, ADP, GTP, UTP 
and possibly other nucleotides as well. These studies have 
also indicated that the binding of these nucleotides to the 
inhibitor site is not P^-sensitive, suggesting that changes 
in P^ alone cannot lead to marked increases in the hexokinase 
rate. Further, it is felt that the partitioning of hexokinase 
activity into soluble and particulate activity pools does not 
represent a dynamic regulatory process. This appears evident 
from the observations that the distribution is not markedly 
affected by even large changes in the glucose-6-P concentra­
tion, and that both ATP and glucose-6-P act to solubilize the 
enzyme. This view is also supported by the recent studies of 
Vallejo et a^. (1970) on the association of bovine brain 
hexokinase with mitochondria. Although it is possible that 
some, yet unknown, factors may also affect rat brain hexo­
kinase, it is now attractive to consider that the regulation 
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of glucose utilization arises chiefly from changes in glucose 
permeation, changes in the levels of glucose-6-P and and 
changes in the size and composition of the free cytoplasmic 
nucleotide pool. 
Finally, it may be of value to discuss briefly some of 
the possible criticisms of the various kinetic approaches 
used here to delineate the regulation of rat brain hexokinase. 
The following partial listing of the assumptions used through­
out this study may serve as a basis for this discussion. We 
have generally assumed that the kinetic properties of hexo-
kinases studies in glass apply in the cell. The hexokinase 
reaction has been considered as an isolated element, rather 
than as a coordinated part of the glycolytic pathway in which 
it participates. It is also assumed that the substrate 
concentrations are much greater than the levels of the enzymes 
acting upon them. Initial rate responses are measured 
throughout, and no attempt has been made to simulate the 
simultaneous variation of more than one parameter at a time. 
In addition, it is tacitly assumed that the simulations of 
intracellular conditions reflect the performance of rat brain 
hexokinase in the cell. All of these assumptions point toward 
our current ignorance of the actual status of ^  vivo chemical 
events, but a brief discussion of these factors may be of 
considerable value. 
Undoubtedly, the kinetic mechanism of any enzyme deter­
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mined ^  vitro can only serve a rough guide to the 
behavior of enzymes in cells. In fact, there is a real need 
for evaluating enzyme kinetic mechanisms and parameters under 
conditions thought to prevail vivo. While it is difficult 
to presently study the effect of numerous metabolites on 
particular enzymes which are present at high concentrations 
in the cell, it is becoming possible for biochemists to 
study the kinetic properties of concentrated enzyme solutions. 
Srere (1967) was among the first to point out the need for 
studying enzymic catalysis and regulation at levels of enzymes 
corresponding to their intracellular concentrations. Only 
recently were the kinetic parameters of several enzymes 
evaluated at such high concentrations (Harwell and Hess, 
1970; Hemphill, Zielke, and Suelter, 1971). The major 
difficulty has been the high rates of enzymic catalysis which 
require the use of fast reaction equipment, usually of the 
stopped-flow type. Alternatively, one may study the reaction 
by conventional means by use of an alternative substrate which 
is acted upon only feebly. This latter approach suffers the 
disadvantage that the enzyme may not behave on the weak alter­
native substrate in a manner analogous to its action on the 
true substrate. Furthermore, the assumption that the total 
substrate concentration is much greater than the enzyme con­
centration may not necessarily hold, and corrections for the 
fraction of total substrate present as the enzyme-substrate 
I 
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Michaelis complex must be employed (Rhoads and Garfinkel, 
1971). To the best of our knowledge, complete kinetic 
studies, designed to elucidate an enzyme's kinetic reaction 
mechanism and evaluate the true rather than apparent Michaelis 
constants, are not available except for several single-sub-
strate systems at levels of 1 yM enzyme or less. Purich and 
Fromm (1972c) recently suggested that the technique of 
isotope exchange at equilibrium may provide a more convenient 
inexpensive means for the probing of kinetic properties of 
highly concentrated enzyme solutions. Because enzyme cata­
lyzed reactions often proceed much more slowly at equilibrium 
than in the absence of the reaction products, it is feasible 
to use very high concentrations of enzyme in isotope exchange 
at equilibrium studies. For example, they found that with 
yeast hexokinase one can use as high as 0.1 mg enzyme/ml of 
assay solution and short incubation periods (0.5 to 1 min) to 
characterize its properties. They also presented a table, 
based upon published equilibrium exchange kinetic data, that 
suggests that many reactions can be studied at concentrations 
as high as 50 mg/ml depending upon their unique kinetic 
parameters. 
As mentioned earlier, the assumption that the substrate 
levels in cells are much greater than the levels of enzymes 
acting upon them may not be valid in a number of cases. Sols 
and Marco (1970) have listed a number of metabolites. 
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including DPNH, fructose-lfG-Pg, glyceraldehyde-3-P, and AMP, 
whose free concentrations in the cell are probably quite low. 
They have presented a systematic explanation for observed 
discrepancies between the total analytical intracellular 
concentration and the free unbound metabolite levels in terms 
of the vivo levels of enzymes, themselves capable of 
strongly binding these metabolites. In the simulations 
presented in this report we have assumed that the enzyme 
binds a negligible portion of the substrate. While this 
assumption is valid vitro and dm vivo for glucose-6-P, the 
adenine nucleotides, GTP, UTP, AND Pi, this assumption may 
not apply for glucose at normal intracellular levels of 
hexokinase and glucose. The extent to which this limitation 
affects the results of our studies remains to be determined. 
Although we have considered brain hexokinase to be an 
isolated element and not as a functionally coordinated part 
of the glycolytic pathway, the results should be applicable 
to the coupled processes. This is probably true because for 
any pathway there are steady-state levels of substrates and 
products, and the responses simulated here can be thought of 
in terms of anticipated responses to changes in the steady-
state level of one or more substrates and products. 
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